General Information of Drug Off-Target (DOT) (ID: OT9A9Q1X)

DOT Name Layilin (LAYN)
Gene Name LAYN
Related Disease
Advanced cancer ( )
Alzheimer disease ( )
Chronic obstructive pulmonary disease ( )
Clear cell renal carcinoma ( )
Colitis ( )
Colon adenocarcinoma ( )
Colon cancer ( )
Gastric adenocarcinoma ( )
Gastric cancer ( )
Glomerulonephritis ( )
Inflammatory bowel disease ( )
Lung adenocarcinoma ( )
Lung carcinoma ( )
Malignant glioma ( )
Neoplasm ( )
Stomach cancer ( )
Osteoarthritis ( )
UniProt ID
LAYN_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00059
Sequence
MRPGTALQAVLLAVLLVGLRAATGRLLSASDLDLRGGQPVCRGGTQRPCYKVIYFHDTSR
RLNFEEAKEACRRDGGQLVSIESEDEQKLIEKFIENLLPSDGDFWIGLRRREEKQSNSTA
CQDLYAWTDGSISQFRNWYVDEPSCGSEVCVVMYHQPSAPAGIGGPYMFQWNDDRCNMKN
NFICKYSDEKPAVPSREAEGEETELTTPVLPEETQEEDAKKTFKESREAALNLAYILIPS
IPLLLLLVVTTVVCWVWICRKRKREQPDPSTKKQHTIWPSPHQGNSPDLEVYNVIRKQSE
ADLAETRPDLKNISFRVCSGEATPDDMSCDYDNMAVNPSESGFVTLVSVESGFVTNDIYE
FSPDQMGRSKESGWVENEIYGY
Function Receptor for hyaluronate.

Molecular Interaction Atlas (MIA) of This DOT

17 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Alzheimer disease DISF8S70 Strong Biomarker [2]
Chronic obstructive pulmonary disease DISQCIRF Strong Biomarker [1]
Clear cell renal carcinoma DISBXRFJ Strong Altered Expression [3]
Colitis DISAF7DD Strong Biomarker [4]
Colon adenocarcinoma DISDRE0J Strong Altered Expression [1]
Colon cancer DISVC52G Strong Biomarker [1]
Gastric adenocarcinoma DISWWLTC Strong Biomarker [1]
Gastric cancer DISXGOUK Strong Altered Expression [1]
Glomerulonephritis DISPZIQ3 Strong Altered Expression [3]
Inflammatory bowel disease DISGN23E Strong Altered Expression [4]
Lung adenocarcinoma DISD51WR Strong Biomarker [5]
Lung carcinoma DISTR26C Strong Biomarker [6]
Malignant glioma DISFXKOV Strong Altered Expression [7]
Neoplasm DISZKGEW Strong Altered Expression [1]
Stomach cancer DISKIJSX Strong Altered Expression [1]
Osteoarthritis DIS05URM Limited Biomarker [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Layilin (LAYN). [9]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Layilin (LAYN). [10]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Layilin (LAYN). [11]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Layilin (LAYN). [12]
Vorinostat DMWMPD4 Approved Vorinostat increases the expression of Layilin (LAYN). [13]
Marinol DM70IK5 Approved Marinol decreases the expression of Layilin (LAYN). [14]
Panobinostat DM58WKG Approved Panobinostat increases the expression of Layilin (LAYN). [15]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Layilin (LAYN). [15]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Layilin (LAYN). [16]
Acetaldehyde DMJFKG4 Investigative Acetaldehyde increases the expression of Layilin (LAYN). [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
2 Identification of prefrontal cortex protein alterations in Alzheimer's disease.Oncotarget. 2018 Jan 24;9(13):10847-10867. doi: 10.18632/oncotarget.24303. eCollection 2018 Feb 16.
3 Roles of layilin in TNF--induced epithelial-mesenchymal transformation of renal tubular epithelial cells.Biochem Biophys Res Commun. 2015 Nov 6;467(1):63-9. doi: 10.1016/j.bbrc.2015.09.121. Epub 2015 Sep 26.
4 Layilin is critical for mediating hyaluronan 35kDa-induced intestinal epithelial tight junction protein ZO-1 in vitro and in vivo.Matrix Biol. 2018 Mar;66:93-109. doi: 10.1016/j.matbio.2017.09.003. Epub 2017 Oct 1.
5 Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers.Carcinogenesis. 2014 Jun;35(6):1248-57. doi: 10.1093/carcin/bgt494. Epub 2014 Jan 7.
6 Down-regulation of layilin, a novel hyaluronan receptor, via RNA interference, inhibits invasion and lymphatic metastasis of human lung A549 cells.Biotechnol Appl Biochem. 2008 Jun;50(Pt 2):89-96. doi: 10.1042/BA20070138.
7 Layilin enhances the invasive ability of malignant glioma cells via SNAI1 signaling.Brain Res. 2019 Sep 15;1719:140-147. doi: 10.1016/j.brainres.2019.05.034. Epub 2019 May 27.
8 Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review.Cartilage. 2019 Jan;10(1):43-52. doi: 10.1177/1947603517749919. Epub 2018 Feb 11.
9 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
10 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
11 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
12 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
13 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
14 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
15 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
16 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
17 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.